menu
    • menu

    Company profile for Diakonos Oncology

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    With multiple FDA clinical trials underway, Diakonos Research is redefining the potential of cancer immunotherapy. Studied both in the lab and in the clinical setting, Diakonos has developed revolutionary approaches to Cancer Immunotherapy that have the ability to address a variety of cancer types. Based in the Houston Medical Center, the sole focus of Diakonos is leveraging the body's natural capability of eliminating cancer....
    With multiple FDA clinical trials underway, Diakonos Research is redefining the potential of cancer immunotherapy. Studied both in the lab and in the clinical setting, Diakonos has developed revolutionary approaches to Cancer Immunotherapy that have the ability to address a variety of cancer types. Based in the Houston Medical Center, the sole focus of Diakonos is leveraging the body's natural capability of eliminating cancer. Using your immune system combined with our patented treatments, Diakonos has repeatedly demonstrated the ability to activate an immune attack against cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Diakonos OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1110 NASA Parkway, Houston, TX 77058, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.diakonosoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/diakonos-oncology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Diakonos Announces First DSMB Safety Review of DOC1021
    Diakonos Announces First DSMB Safety Review of DOC1021

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diakonos-oncology-announces-study-to-continue-after-first-dsmb-safety-review-of-doc1021-in-phase-2-gbm-study-302688898.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    Diakonos Oncology to Present, Join Panel at Biotech 2026
    Diakonos Oncology to Present, Join Panel at Biotech 2026

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diakonos-oncology-to-present-corporate-overview-and-participate-in-panel-at-2026-biotech-showcase-302641688.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    CPRIT Funds Diakonos for DOC1021 Melanoma Therapy
    CPRIT Funds Diakonos for DOC1021 Melanoma Therapy

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diakonos-oncology-awarded-multi-million-dollar-research-grant-by-the-cancer-prevention-and-research-institute-of-texas-to-advance-doc1021-in-refractory-melanoma-302637446.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Diakonos Oncology Unveils Positive Phase 1 Data For DOC1021
    Diakonos Oncology Unveils Positive Phase 1 Data For DOC1021

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diakonos-oncology-presents-promising-preliminary-data-from-phase-1-study-of-doc1021-cell-based-immunotherapy-in-pancreatic-cancer-at-society-for-immunotherapy-of-cancer-40th-annual-meeting-302608210.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share
    Diakonos Oncology To Present DOC1021 Immunotherapy Data At SITC
    Diakonos Oncology To Present DOC1021 Immunotherapy Data At SITC

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pancreatic-cancer-clinical-trial-data-for-diakonos-oncologys-doc1021-cell-based-immunotherapy-to-be-presented-at-the-society-for-immunotherapy-of-cancer-sitc-40th-annual-meeting-302594102.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Diakonos Oncology doses first patient in DOC1021 trial
    Diakonos Oncology doses first patient in DOC1021 trial

    22 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diakonos-oncology-announces-first-patient-dosed-in-phase-2-clinical-trial-evaluating-doc1021-dubodencel-for-glioblastoma-302510208.html

    PR NEWSWIRE
    22 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search